EVMN

NYSEStock

Evommune, Inc.

$21.63-1.35 (-5.87%)

52-Week Range

$15.01
$31.57

Key Stats

Market Cap

278.4M

P/E Ratio

Dividend Yield

Beta

0.00

Volume

197.4K

Avg Volume

325.6K

Performance

1M

-17.58%

3M

+30.35%

6M

+13.59%

YTD

+32.76%

1Y

+13.59%

3Y

+13.59%

5Y

+13.59%

Price Chart

ETF Exposure

EVMN is held by 15 ETFs

ETFFund NameWeight
ACSGAmerican Century Small Cap Growth Insights ETF0.20%
JDOCJPMorgan Healthcare Leaders ETF0.17%
SCHASchwab U.S. Small-Cap ETF0.01%
VXFVanguard Extended Market ETF0.00%
VTWGVanguard Russell 2000 Growth ETF0.00%
VTWOVanguard Russell 2000 ETF0.00%
VTWVVanguard Russell 2000 Value ETF0.00%
SCHBSchwab U.S. Broad Market ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
VTHRVanguard Russell 3000 ETF0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%

About EVMN ETF Exposure

Evommune, Inc. (EVMN) is held by 15 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 278.4M, EVMN is a widely held institutional stock. The stock currently trades at $21.63. Investors can gain exposure to EVMN through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold EVMN, sorted by portfolio weight.